MicroTransponder®, Inc. is a commercial stage company committed to developing research-based neuroscience solutions. The Company focuses on restoring independence and dignity for people suffering from neurological conditions that impair sensory and motor function. MicroTransponder’s FDA-approved Vivistim® Paired VNS™ System is a first-of-its-kind, clinically proven therapy that generates two to three times more improvement in upper limb function than rehabilitation alone for stroke survivors.